Condition: Diabetic Ketoacidosis · Sponsor: The George Institute
The goal of this blinded, cluster cross-over, randomised controlled trial is to determine whether fluid therapy with Plasma-Lyte® 148 increases the number of days alive and days out of hospital to day-28 compared to 0.9% sodium chloride ('0.9% saline') in critically ill patients presenting to the Emergency Department (ED) and deemed to require admission to a critical care area (ICU, HDU) with moderate to severe diabetic ketoacidosis (DKA).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Blacktown Hospital | Blacktown, New South Wales, Australia | Recruiting |
| Camperdown Hospital | Camperdown, New South Wales, Australia | Recruiting |
| Dubbo Base Hospital | Dubbo, New South Wales, Australia | Recruiting |
| St George Hospital | Kogarah, New South Wales, Australia | Recruiting |
| Maitland Hospital | Metford, New South Wales, Australia | Recruiting |
| Orange Hospital | Orange, New South Wales, Australia | Recruiting |
| Royal North Shore Hospital | St Leonards, New South Wales, Australia | Recruiting |
| Westmead Hospital | Westmead, New South Wales, Australia | Recruiting |
| Sunshine Coast University Hospital | Birtinya, Queensland, Australia | Recruiting |
| Caboolture Hospital | Caboolture, Queensland, Australia | Recruiting |
| Queen Elizabeth II Jubilee Hospital | Coopers Plains, Queensland, Australia | Recruiting |
| Redcliffe Hospital | Redcliffe, Queensland, Australia | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05752279